首页> 外文期刊>Diabetes therapy >Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study
【24h】

Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study

机译:遵守希腊2型糖尿病患者的后续议定书的国家准则:概览研究

获取原文
           

摘要

Introduction Physician adherence, or lack therefore, to diabetes care and follow-up guidelines may be linked to the rates of achieving suboptimal glycaemic, blood pressure and lipid targets in people with type 2 diabetes mellitus (T2DM). In this cross-sectional study we evaluated physician adherence to the patient follow-up protocol (PFP) of the 2017 Hellenic Diabetes Association (HDA) guidelines and also assessed glycated haemoglobin (HbAsub1c/sub), blood pressure and lipid control achievement rates in the routine care setting in Greece.MethodsEligible subjects were adults with T2DM receiving oral hypoglycaemic agents (OHAs) for ≥ 1?year who had ≥ 2 HbAsub1c/sub measurements in the previous year and an HbAsub1c/sub target??7%. Overall adherence at the subject level was defined as the percentage of the 62 HDA PFP items that had been met during the past year.ResultsBetween June and December 2018, 601 eligible subjects (54.6% men; mean age 65.2?years; median T2DM duration 5.9?years, of whom 96.5% had?≥?1 medical condition/comorbidity), were enrolled into the study by 53 hospital- and office-based endocrinologists, internists and general practitioners. The main OHAs prescribed at enrolment were metformin (91.0%), dipeptidyl peptidase-4 inhibitors (60.7%), sodium-glucose co-transporter-2 inhibitors (23.5%) and sulphonylureas (16.3%). Mean overall physician adherence to the PFP was 43.6%. Predictors of greater higher physicans’ adherence were female sex ( p =?0.026),??3 medical conditions/comorbidities ( p =?0.043) and diabetic complications ( p ?0.001). HbAsub1c/sub, low-density lipoprotein-cholesterol, systolic/diastolic blood pressure and composite metabolic targets were achieved by 82.1, 57.0, 42.6 and 21.6% of subjects, respectively.ConclusionsIn Greek routine care, physician adherence to the PFP of the 2017 HDA guidelines is suboptimal. Future efforts should focus on identifying the barriers to an adequate adherence by physicians to the full PFP, with the aim to provide optimal patient care.
机译:引言医师遵守或缺乏对糖尿病护理和后续准则可能与患有2型糖尿病(T2DM)的人的次优血糖,血压和脂质靶标相关联。在这个横断面研究中,我们评估了2017年Hellenic糖尿病协会(HDA)指南的患者随访协议(PFP)的医生依从性(HDA)指南,还评估了糖化血红蛋白(HBA 1c ),血压和希腊常规护理环境中的脂质控制成就率。在≥1?年龄≥1岁的人的成年人(OHAS)是≥2HBA 1c 测量的≥1〜1岁的成年人HBA 1c 目标?<?7%。主题级别的整体遵守被定义为过去一年中遇到的62个HDA PFP项目的百分比。六月和2018年12月,601个符合条件的科目(54.6%的人;平均年龄为65.2岁?年;中位数T2DM持续时间5.9 ?多年来,其中96.5%有96.5%?≥?1个医疗条件/合并症),由53名医院和办公室的内分泌学家,内科医生和一般从业者注册研究。在注册中规定的主要ohas是二甲双胍(91.0%),二肽基肽酶-4抑制剂(60.7%),钠葡萄糖共转运蛋白-2抑制剂(23.5%)和磺酰脲(16.3%)。意味着整体医生依从于PFP为43.6%。更高的物理学的预测因素是女性性别(p = 0.026),?> 3疗法/可糖尿病(p = 0.043)和糖尿病并发症(p <0.001)。通过82.1,57.0,42.6和21.6%的受试者实现了低密度脂蛋白 - 胆固醇,低密度脂蛋白 - 胆固醇,收缩期/舒张压血压和复合代谢靶标。关于希腊常规护理,医生遵守2017年HDA指南的PFP是次优。未来的努力应侧重于将医生对全面PFP充分遵守的障碍,其目的是提供最佳的患者护理。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号